Higashikuni Lab
Higashikuni Lab
Home
Projects
Posts
Talks
People
Publications
Contact
Light
Dark
Automatic
RNA Metabolism and Modification
RNA Metabolism and Modification in Cardiovascular disease
Deciphering RNA metabolism and modification in pathogenic mechanism of heart failure for development of novel therapeutic strategies.
How Inflammation Causes Heart Failure
We will discuss how inflammation is initiated in the stressed heart and causes heart failure.
Dec 16, 2023 9:00 AM — 10:30 AM
Osaka
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Novel Therapeutic Strategy for Cardiovascular Disease
Based on our basic research findings and clinical experience, we will discuss next-generation therapeutic strategy for cardiovascular disease.
Nov 11, 2023 9:00 AM — 6:00 PM
Tokyo, Online
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
Heart Failure and Inflammation
We will discuss how inflammation is initiated in the stressed heart and causes heart failure.
Oct 30, 2023 6:00 PM — 7:30 PM
Tokyo, Online
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Diabetes in Cardiovascular Medicine
Synthetic biology approach for the treatment of diabetes and cardiovascular disease will be discussed.
Sep 6, 2022 7:00 PM — 8:30 PM
Tokyo, Online
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
Linking RNA dynamics to heart disease: the lncRNA/miRNA/mRNA axis in myocardial ischemia-reperfusion injury
Wenhao Liu, M.D.
,
Yasutomi Higashikuni, M.D., Ph.D., FESC
,
Masataka Sata
Project
DOI
Hyperuricemia in Cardiovascular Medicine
Our basic research findings provide new insight into therapeutic strategy for hyperuricemia in patients with cardiovascular disease.
May 26, 2022 7:00 PM — 8:00 PM
Tokyo, Online
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
Homeostatic Inflammation in Heart Disease
How inflammation is regulated in the heart and contributes to the transition from adaptive cardiac hypertrophy to heart failure will be discussed.
Mar 13, 2022 9:00 AM — 12:00 PM
Kobe, Online
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Next-Generation Gene Therapy for Heart Failure
Our next-generation gene therapy for heart failure enables personalized medicine at cellular level.
Jul 26, 2020 11:00 PM — Aug 2, 2020 8:00 AM
Kyoto, Online
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Cite
×